Skip to main content
All lobbying filings

Capitol Hill Consulting Group

Capitol Hill Consulting Group filed a Q1 report for Goodrx, Inc. on April 21, 2026, reporting $60,000 in lobbying income.

Lobbying for Goodrx, Inc. · Consumer-focused digital healthcare platform to help make prescription drugs more affordab

As filed: CAPITOL HILL CONSULTING GROUP for GOODRX, INC.

All filings by Capitol Hill Consulting Group · Everything Goodrx, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 21, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 4
  • CHRISTOPHER DAVIS
    Previously held: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).
  • EMILY ELIZABETH WILKINSON-HOLLAND
    Previously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).
  • KIMBERLEE TRZECIAK New on this filing
    Previously held: FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA
  • BRIAN SUTTER
    Previously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues surrounding ways to lower prescription drug costs. Issues related to direct to consumer access

Issues surrounding ways to lower prescription drug costs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem